Santen Pharmaceutical Co. Ltd.
SNPHY | OTC
$11.23
+$0.45 (+4.17%)
At close: Oct 30, 2026, 3:15 PM ET
$11.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Market Data
Market Cap $3.64B
Enterprise Value $544.51B
Beta 0.24
Average Volume 2.62K
Shares Outstanding (Diluted) 322.6M
Shares Change YoY -5.16%
Institutional Ownership 0.00%
Exchange OTC
ISIN US80287P1003
Price Performance
Price Change 1M 3.5%
Price Change 3M -5.1%
Price Change 6M 12.0%
Price Change YTD 9.0%
Price Change 1Y 12.6%
Price Change 3Y 29.3%
Price Change 5Y -20.4%
1M CAGR (ann.) 2.3%
1Y CAGR (ann.) 19.1%
5Y CAGR (ann.) -2.5%
All-Time CAGR -0.5%
Valuation
PE Ratio 14.57
Forward PE 14.00
PEG Ratio 0.50
Forward PEG 0.65
PS Ratio 1.92
Forward PS 1.90
PB Ratio 1.97
P/FCF Ratio 16.00
P/Adj. FCF Ratio 16.00
P/OCF Ratio 13.56
EV/Sales 1.87
EV/EBIT 11.05
EV/EBITDA 8.02
EV/FCF 15.51
Earnings Yield 6.7%
FCF Yield 6.1%
Adj. FCF Yield 6.1%
Financial Health
Net Cash ¥47.25B
Total Debt ¥31.01B
Cash & Short-Term Investments ¥78.26B
Total Assets ¥415.85B
Current Ratio 2.82
Quick Ratio 1.98
Debt / Equity Ratio 0.10
Debt / EBITDA 0.46
Debt / FCF 0.88
OCF / Debt 1.32
Interest Coverage 23.07
Altman Z-Score 5.31
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 56.1%
Operating Profit Margin 15.7%
EBITDA Margin 23.3%
Net Profit Margin 13.3%
FCF Margin 12.0%
Adj. FCF Margin 12.0%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 9.3%
Return on Equity 13.4%
Return on Invested Capital 10.9%
Return on Capital Employed 13.5%
Return on Tangible Assets 11.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 0.7%
Revenue CAGR 5Y 2.6%
Revenue CAGR 10Y 4.0%
EPS CAGR 3Y 23.2%
EPS CAGR 5Y 35.0%
EPS CAGR 10Y -0.7%
FCF CAGR 3Y 19.2%
FCF CAGR 5Y 3.9%
FCF CAGR 10Y 5.8%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date May 11, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $3.29M
Revenue Growth Est (next Q) -2.2%
Fair Value Estimates
Graham Number $9.71
Graham Upside -13.5%
Lynch Fair Value $19.26
Lynch Upside 71.5%
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow ¥41.04B
Free Cash Flow ¥35.1B
Adj. Free Cash Flow ¥35.1B
FCF Per Share $109.22
OCF Per Share $127.71
OCF/S Ratio 14.1%
Income Statement
Revenue ¥291.84B
Gross Profit ¥163.72B
Operating Income ¥45.75B
EBITDA ¥67.88B
Net Income ¥38.68B
EPS (Diluted) $118.82
Revenue / Employee $73.55M
Profit / Employee $9.75M
Employees 3,968
Dividends
Annual Dividend $0.23
Dividend Yield 2.05%
Payout Ratio 0.2%
FCF Payout Ratio 35.0%
Adj. FCF Payout Ratio 35.0%
Dividend Growth (YoY) -9.8%
Pay Frequency Semi-Annual
Ex-Dividend Date Sep 29, 2026
Add to Watchlist
Select watchlists to add or remove SNPHY